CIMPRESS plc
For the period ended Dec 31, 2024. Filed Jan 31, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Dec 31, 2024 · Filed Jan 31, 2025
CMPR$56.52+2.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Shareholders' Deficit for the
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' DEFICIT
| Ordinary Shares · Treasury Shares | ||||||||
|---|---|---|---|---|---|---|---|---|
| Number ofSharesIssued | Amount | NumberofShares Issued | Amount | AdditionalPaid-inCapital | RetainedEarnings | Accumulated OtherComprehensiveLoss | TotalShareholders’Deficit | |
| Balance at June 30, 2023 | 44,316 | $615 | (17,971) | $(1,363,550) | $539,454 | $235,396 | $(35,060) | $(623,145) |
| Issuance of ordinary shares due to share option exercises, net of shares withheld for taxes | 2 | — | — | — | 82 | — | — | 82 |
| Share-based awards vested, net of shares withheld for taxes | 236 | — | — | — | (8,403) | — | — | (8,403) |
| Share-based compensation expense | — | — | — | — | 12,621 | — | — | 12,621 |
| Net income attributable to Cimpress plc | — | — | — | — | — | 4,554 | — | 4,554 |
| Redeemable noncontrolling interest accretion to redemption value | — | — | — | — | — | (330) | — | (330) |
| Net unrealized gain on derivative instruments designated and qualifying as cash flow hedges | — | — | — | — | — | — | 4,131 | 4,131 |
| Foreign currency translation, net of hedges | — | — | — | — | — | — | (3,693) | (3,693) |
| Balance at September 30, 2023 | 44,554 | $615 | (17,971) | $(1,363,550) | $543,754 | $239,620 | $(34,622) | $(614,183) |
| Issuance of ordinary shares due to share option exercises, net of shares withheld for taxes | — | — | — | — | 6 | — | — | 6 |
| Share-based awards vested, net of shares withheld for taxes | 50 | 6 | — | — | (1,792) | — | — | (1,786) |
| Share-based compensation expense | — | — | — | — | 18,051 | — | — | 18,051 |
| Net income attributable to Cimpress plc | — | — | — | — | — | 58,105 | — | 58,105 |
| Redeemable noncontrolling interest accretion to redemption value | — | — | — | — | — | (135) | — | (135) |
| Net unrealized loss on derivative instruments designated and qualifying as cash flow hedges | — | — | — | — | — | — | (10,216) | (10,216) |
| Foreign currency translation, net of hedges | — | — | — | — | — | — | (2,385) | (2,385) |
| Balance at December 31, 2023 | 44,604 | $621 | (17,971) | $(1,363,550) | $560,019 | $297,590 | $(47,223) | $(552,543) |
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' DEFICIT (CONTINUED)
| Ordinary Shares · Treasury Shares | ||||||||
|---|---|---|---|---|---|---|---|---|
| Number ofSharesIssued | Amount | NumberofShares Issued | Amount | AdditionalPaid-inCapital | RetainedEarnings | Accumulated OtherComprehensiveLoss | TotalShareholders’Deficit | |
| Balance at June 30, 2024 | 43,051 | $604 | (17,971) | $(1,363,550) | $570,283 | $272,881 | $(30,364) | $(550,146) |
| Issuance of ordinary shares due to share option exercises, net of shares withheld for taxes | 22 | — | — | — | 1,000 | — | — | 1,000 |
| Purchase and cancellation of ordinary shares | (123) | (1) | — | — | (1,713) | (8,906) | — | (10,620) |
| Share-based awards vested, net of shares withheld for taxes | 282 | 3 | — | — | (12,951) | — | — | (12,948) |
| Share-based compensation expense | — | — | — | — | 16,573 | — | — | 16,573 |
| Net loss attributable to Cimpress plc | — | — | — | — | — | (12,549) | — | (12,549) |
| Redeemable noncontrolling interest accretion to redemption value | — | — | — | — | — | (503) | — | (503) |
| Net unrealized loss on derivative instruments designated and qualifying as cash flow hedges | — | — | — | — | — | — | (8,115) | (8,115) |
| Foreign currency translation, net of hedges | — | — | — | — | — | — | 6,319 | 6,319 |
| Balance at September 30, 2024 | 43,232 | $606 | (17,971) | $(1,363,550) | $573,192 | $250,923 | $(32,160) | $(570,989) |
| Issuance of ordinary shares due to share option exercises, net of shares withheld for taxes | 7 | — | — | — | 369 | — | — | 369 |
| Purchase and cancellation of ordinary shares | (534) | (6) | — | — | (7,352) | (35,009) | — | (42,367) |
| Restricted share units vested, net of shares withheld for taxes | 84 | 1 | — | — | (3,823) | — | — | (3,822) |
| Share-based compensation expense | — | — | — | — | 14,495 | — | — | 14,495 |
| Net income attributable to Cimpress plc | — | — | — | — | — | 61,057 | — | 61,057 |
| Redeemable noncontrolling interest accretion to redemption value | — | — | — | — | — | 591 | — | 591 |
| Net unrealized gain on derivative instruments designated and qualifying as cash flow hedges | — | — | — | — | — | — | 7,498 | 7,498 |
| Foreign currency translation, net of hedges | — | — | — | — | — | — | (21,300) | (21,300) |
| Balance at December 31, 2024 | 42,789 | $601 | (17,971) | $(1,363,550) | $576,881 | $277,562 | $(45,962) | $(554,468) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.